Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07126184Completed

Incidence and Predictors of Recurrent Stroke in Cryptogenic Stroke Patients With Atrial Fibrillation

Role: lead

NCT07125014Completed

Frequency and Predictors of Post-ERCP Pancreatitis in a South Asian Tertiary Care Center

Role: lead

NCT02876549Phase 4Completed

G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria

Role: collaborator

All 3 trials loaded